Cargando…

Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment

This study aimed to investigate the effect of gonadotropin-releasing hormone agonist (GnRHa) treatment on the expression of neuritin 1 (NRN1) in women with ovarian endometriosis. We collected tissues and serum from women with endometriosis treated with (n = 45) or without (n = 37) GnRHa. NRN1 mRNA a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahmawati, Endah, Yang, Wei-Chung Vivian, Lei, Yen-Ping, Maurya, Pawan Kumar, Chen, Huei-Wen, Tzeng, Chii-Ruey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770869/ https://www.ncbi.nlm.nih.gov/pubmed/31491902 http://dx.doi.org/10.3390/ijms20184352

Ejemplares similares

The impact of phthalate on reproductive function in women with endometriosis
por: Chou, Ya‐Ching, et al.
Publicado: (2021)

Increased Risk of Pneumonia in Patients Receiving Gonadotropin-Releasing Hormone Agonists for Prostate Cancer
por: Chung, Shiu-Dong, et al.
Publicado: (2014)

Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis
por: Lee, Dong-Yun, et al.
Publicado: (2016)

Rapidly growing extensive polypoid endometriosis after gonadotropin-releasing hormone agonist discontinuation: A case report
por: Zhang, De-Yu, et al.
Publicado: (2023)

Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies
por: Lin, Yi-Heng, et al.
Publicado: (2018)

Neuritin can normalize neural deficits of Alzheimer's disease
por: An, K, et al.
Publicado: (2014)

Neuritin, unmasked as a checkpoint for the pathogenesis of allergy and autoimmunity
por: Lucas, Michaela, et al.
Publicado: (2021)

Neuritin inhibits astrogliosis to ameliorate diabetic cognitive dysfunction
por: Zhang, Zuo, et al.
Publicado: (2021)

Expression of neuritin in human lung squamous cell carcinoma
por: Liang, Mengjie, et al.
Publicado: (2019)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis
por: Tamura, Hiroshi, et al.
Publicado: (2014)

Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density
por: Cho, Young Hwa, et al.
Publicado: (2016)

Gonadotropin-releasing hormone agonist contributes to the successful implementation of in vitro fertilization in a patient with cervical endometriosis: a case report
por: Yang, Turui, et al.
Publicado: (2023)

LGI1 governs neuritin-mediated resilience to chronic stress
por: Lee, Seung Hoon, et al.
Publicado: (2021)

Establishment and Functional Characterization of Murine Monoclonal Antibodies Recognizing Neuritin
por: Papadogianni, Georgia, et al.
Publicado: (2023)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
por: Keane, Fergus, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
por: Shiasi Arani, Kobra, et al.
Publicado: (2015)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

Neuritin affects the activity of neuralized-like 1 by promoting degradation and weakening its affinity for substrate: Neuritin regulates the activity of the E3 ligase NEURL1
por: Zhu, Jingling, et al.
Publicado: (2023)

Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
por: Rzewuska, Anna Maria, et al.
Publicado: (2023)

Erratum to: Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density
por: Cho, Young Hwa, et al.
Publicado: (2017)

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

miR-199a decreases Neuritin expression involved in the development of Alzheimer's disease in APP/PS1 mice
por: Song, Dandan, et al.
Publicado: (2020)

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve
por: Lin, Ming-Huei, et al.
Publicado: (2019)

Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study
por: Chou, Szu-Yuan, et al.
Publicado: (2020)

Neuritin Attenuates Neuronal Apoptosis Mediated by Endoplasmic Reticulum Stress In Vitro
por: Sun, Xiaokun, et al.
Publicado: (2018)

Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors
por: Finch, Ann R., et al.
Publicado: (2009)

The role of gonadotropin-releasing hormone agonists in female fertility preservation
por: Lee, Jae Hoon, et al.
Publicado: (2021)

Low oxygen tension increases mitochondrial membrane potential and enhances expression of antioxidant genes and implantation protein of mouse blastocyst cultured in vitro
por: Ma, Yun-Yi, et al.
Publicado: (2017)

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
por: Shebley, Mohamad, et al.
Publicado: (2019)

Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)
por: de Oliveira, Sofia Andrade, et al.
Publicado: (2016)

Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats
por: TUNGMAHASUK, Doungrut, et al.
Publicado: (2017)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
por: Halim, Binarwan, et al.
Publicado: (2022)

Neuritin Inhibits Notch Signaling through Interacted with Neuralized to Promote the Neurite Growth
por: Zhang, Pan, et al.
Publicado: (2017)

Exposure to Mono-n-Butyl Phthalate in Women with Endometriosis and Its Association with the Biological Effects on Human Granulosa Cells
por: Chou, Ya-Ching, et al.
Publicado: (2020)

A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
por: Zhou, Feng, et al.
Publicado: (2016)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?
por: Yilmaz, Nafiye, et al.
Publicado: (2019)

Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer
por: Mastandrea, Katherine, et al.
Publicado: (2023)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3knhcg19609676661cbsgrntfs